Iatrogenic Cost Factors Incorporating Mild and Moderate Adverse Events in the Economic Comparison of Aceclofenac and Other NSAIDs

Author： Peris F.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.7, 2001-07, pp. : 779-790

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pimecrolimus cost effective in mild to moderate atopic dermatitis

By  

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Pimecrolimus cost effective in mild to moderate atopic dermatitis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 503, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Aceclofenac worth its cost

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 327, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Aceclofenac worth its cost

By  

Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Preventable adverse events cost UK NHS dearly

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 303, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite